Literature DB >> 1762571

Molecular design and modeling of protein-heparin interactions.

A D Cardin, D A Demeter, H J Weintraub, R L Jackson.   

Abstract

The methods and approaches taken to investigate heparin-apoE peptide interactions have involved a series of steps, including (1) identification of the heparin-binding domains of apoE, (2) determination of the minimal amino acid sequence regions involved in heparin binding, heparin-induced conformational changes, and stability of apoE peptide structures in solution, (3) modeling of these peptide and oligosaccharide structures, and (4) examination of their behavior during molecular dynamics calculations to determine if the modeled complexes simulate the results of the solution study. The heparin-binding regions of apoE were determined by fragmentation of the protein and identification of the heparin-binding fragments by ligand-blotting procedures using 125I-labeled heparin. Studies with synthetic peptide fragments of various lengths and dot-blot procedures with 125I-labeled heparin identified the minimal residues critical for heparin-binding and CD studies established the prominent secondary structures of these domains. These studies also showed that heparin binds to the apoE(211-243) and apoE(129-169) regions to induce and stabilize beta-strand and alpha-helical peptide conformations. Secondary structure algorithms were used to identify the specific residues with the highest probabilities of forming alpha-helix and beta-strand structures. Based on the predictive algorithms, the apoE(211-234) and apoE(129-159) structures were built using the Insight program and their molecular interactions with various heparin oligosaccharide models were investigated by molecular dynamics. In agreement with the solution studies in the presence of salt, the molecular dynamics studies showed that the oligosaccharides stabilized the beta-strand and alpha-helical peptide configurations against simulated thermal denaturations. Further modeling studies are in progress to examine the mechanism of the heparin-induced increase in ordered structure of these peptides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1762571     DOI: 10.1016/0076-6879(91)03030-k

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  13 in total

1.  Sulfated polysaccharide-directed recruitment of mammalian host proteins: a novel strategy in microbial pathogenesis.

Authors:  T D Duensing; J S Wing; J P van Putten
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense.

Authors:  S A Smith; N P Mullin; J Parkinson; S N Shchelkunov; A V Totmenin; V N Loparev; R Srisatjaluk; D N Reynolds; K L Keeling; D E Justus; P N Barlow; G J Kotwal
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Two domains within the Mycoplasma hyopneumoniae cilium adhesin bind heparin.

Authors:  Cheryl Jenkins; Jody L Wilton; F Chris Minion; Linda Falconer; Mark J Walker; Steven P Djordjevic
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Modulation of Ca2+ channels, charge movement and Ca2+ transients by heparin in frog skeletal muscle fibres.

Authors:  M Martínez; M C García; J M Farías; H Cruzblanca; J A Sánchez
Journal:  J Muscle Res Cell Motil       Date:  1996-10       Impact factor: 2.698

5.  Porin polypeptide contributes to surface charge of gonococci.

Authors:  J Swanson; D Dorward; L Lubke; D Kao
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

6.  Interaction of heparin with synthetic peptides corresponding to the C-terminal domain of intestinal mucins.

Authors:  G Xu; G G Forstner; J F Forstner
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

7.  Low anticoagulant heparin blocks thrombin-induced endothelial permeability in a PAR-dependent manner.

Authors:  Joyce N Gonzales; Kyung-mi Kim; Marina A Zemskova; Ruslan Rafikov; Brenten Heeke; Matthew N Varn; Stephen Black; Thomas P Kennedy; Alexander D Verin; Evgeny A Zemskov
Journal:  Vascul Pharmacol       Date:  2014-01-25       Impact factor: 5.773

8.  N.m.r. and molecular-modelling studies of the solution conformation of heparin.

Authors:  B Mulloy; M J Forster; C Jones; D B Davies
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

Review 9.  Bordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential.

Authors:  Erich V Scheller; Peggy A Cotter
Journal:  Pathog Dis       Date:  2015-09-27       Impact factor: 3.166

10.  Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies.

Authors:  D R Wilson; A Siebers; B B Finlay
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.